http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006057674-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52389ab2341f3c6159207c0b247725d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_857763bdcd149edc5708fb87d0f0dbbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8909b5f9931c800adcc6688cca00d8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-04
filingDate 2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9942ec887d9a6bd63479cd943e33025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a63c51e883cf7f99a250433472c6a3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7158c0785af7d6a34dc429bd4ffa606
publicationDate 2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006057674-A3
titleOfInvention COMPOSITIONS AND METHODS FOR EX VIVO PRESERVATION OF BLOOD VESSELS FOR VASCULAR GRAFTS USING ANALOGUES OF cAMP AND cGMP
abstract The present invention relates to ex vivo methods for preserving/maintaining blood vessels that are to be used as vascular grafts. The present invention also relates to compositions comprising an analogue of cAMP and/or an analogue of cGMP for use in the methods of the invention, which compositions are free of: (i) an inhibitor of Type I phosphodiesterase, (ii) an inhibitor of Type II phosphodiesterase, (iii) an inhibitor of Type III phosphodiesterase, (iv) an inhibitor of Type IV phosphodiesterase, and (v) an inhibitor of TNF-α.
priorityDate 2004-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6794124-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6365338-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5370989-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394037
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527025
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403922
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25322948

Total number of triples: 34.